
In situations where supplies are limited, the National Institutes of Health’s COVID-19 Treatment Guidelines Panel recommended prioritizing remdesivir for use in hospitalized patients with COVID-19 who require supplemental oxygen but are not mechanically ventilated or on extracorporeal membrane oxygenation.